Metabolomics in biomarker discovery and functional genomics

Dr. Giuseppe Astarita
Senior Director for biomarker discovery
Arkuda Therapeutics, Watertown, MA

talks about how metabolomics and lipidomics support drug development and why it is so crucial to work with quantitative metabolomics data in biomarker discovery.

Includes data of the new biocrates MxP® Quant 500 XL platform.

LinkedIn: gastarita

https://biocrates.com

• #science_technology
• #biocrates
• #metabolomics
• #phenotyping
• #genomics
• #biomarker